Hugel Inc. | Mutual Funds
Mutual Funds that own Hugel Inc.
Government Pension Fund - Global (The)
83,888
1.93%
66,190
0%
12/31/2017
AllianceBernstein - Emerging Markets Growth Portfolio
53,990
1.24%
0
2.04%
07/31/2018
51,362
1.18%
0
3.05%
04/30/2018
Macquarie Unit Trust Series - Asia New Stars Fund
50,988
1.17%
0
3.1%
04/30/2018
Ivy Emerging Markets Equity Fund
42,116
0.97%
10,336
0.69%
06/30/2018
Vanguard Total International Stock Index Fund
32,967
0.76%
3,076
0%
07/31/2018
Sanford C Bernstein Fund - Emerging Markets Portfolio
31,184
0.72%
250
0.9%
07/31/2018
Columbia Seligman Global Technology Fund
28,436
0.65%
0
0.86%
05/31/2018
HSBC GIF - Asia (ex-Japan) Equity Smaller Companies
28,393
0.65%
-7,800
0.8%
03/31/2018
Macquarie Asia New Stars No.1 Fund (Top 5 Holdings)
23,761
0.55%
-2,641
2.7%
02/28/2018
| Address |
61-20 Sinbuk-ro
Chuncheon-si GA 24206
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.hugel.co.kr |
| Updated |
09/14/2018 |
| Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea. |
